“Pharmaceutical companies made obscene profits off the pandemic while people were dying. They prioritized money over lives and should be held accountable.”
There's a real tension here. Pharma companies did deliver vaccines in record time, saving lives. But the billions in profits, liability shields, lack of pricing transparency, and suppression of generic alternatives are legitimate concerns — ones conservatives have been raising about corporate-government collusion for years.
Key Talking Points
- 1Pfizer earned $100 billion in COVID vaccine and Paxlovid revenue in 2021-2022, built partly on $18 billion in taxpayer-funded Operation Warp Speed
- 2Under the PREP Act, manufacturers received broad lawsuit immunity — the CICP approved fewer than 10 injury claims out of thousands filed
- 3The problem was crony capitalism — government mandates created a captive market with no liability, not free-market dynamics
- 4Reform should target the revolving door between pharma and regulators, not create more government control
The Full Response
This is an area where left-wing criticism and conservative concerns actually overlap significantly — though the proposed solutions differ dramatically. The pharmaceutical industry's pandemic profits deserve scrutiny, and conservatives should not reflexively defend Big Pharma simply because the left attacks it.
The numbers are staggering. Pfizer reported $100 billion in combined revenue from its COVID vaccine and Paxlovid treatment in 2021 and 2022. Moderna, which had never brought a product to market before the pandemic, generated $36 billion in COVID vaccine revenue over the same period. These profits were built on a foundation of massive public investment — the U.S. government provided approximately $18 billion through Operation Warp Speed to fund vaccine development and guarantee purchases.
The liability protections are equally notable. Under the PREP Act, vaccine manufacturers received broad immunity from lawsuits related to adverse events. The National Vaccine Injury Compensation Program's Countermeasures Injury Compensation Program (CICP), which handles COVID vaccine injury claims, had approved fewer than 10 claims out of thousands filed as of 2023, with a compensation rate dramatically lower than the traditional vaccine injury program.
However, the conservative response should differ from the progressive one. The left typically proposes more government control — price controls, nationalization of pharmaceutical development, or expanded regulation. But the pandemic actually demonstrated the problem with too much government-industry entanglement, not too little. The revolving door between pharmaceutical companies and regulatory agencies, the suppression of potential generic treatments that might have competed with patented vaccines, and the use of government mandates to guarantee a captive market — these are symptoms of crony capitalism, not free-market failure.
The real reform agenda should include: ending the revolving door between pharma and regulatory agencies, requiring full transparency on public funding contributions to drug development, reforming the liability shield so that manufacturers face normal product liability incentives, enabling international competition and importation of cheaper alternatives, and ensuring that emergency use authorization is not used to short-circuit normal safety evaluation timelines.
Conservatives can and should be clear-eyed about pharmaceutical industry excess while recognizing that the answer is less government-industry collusion and more market accountability — not the government takeover that progressives propose.
How to Say It
This is a rare area of bipartisan agreement on the problem — use that common ground. Agree that pharma profits were excessive, then redirect toward the conservative diagnosis: the issue is government-industry collusion, not capitalism itself.
Sources — The Receipts
- •
- •
- •
- •
Community Responses
Have a great response to this argument? Share it below. Approved responses appear for everyone.